Q4 total revenue grew 34% year-over-year to $76.4 million; fiscal year total revenue grew 32% to $269.5 million Q4 recurring revenue grew 40% year-over-year to $70.0 million; fiscal year recurring revenue grew 42% to $249.2 million ARR grew 37% year-over- …
SANTA MONICA, Calif., March 04, 2021 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines to treat addictions and drug overdose, today reported financial results for the fourth …
DEER PARK, Ill., March 04, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative treatments for rare pediatric diseases, today announced that it will …
- Grows Revenue 23% Quarterly and 21% Annually, Compared to 2019 - - Reports Record Annual Operating Income of $5.5 Million, Up 61% Compared to 2019 - - Posts Record Adjusted EBITDA of $9.1 Million, Up 47% Compared to 2019 - - Increases Total Clinic Count …
ORLANDO, Fla., March 04, 2021 (GLOBE NEWSWIRE) -- Franchise Group, Inc. (NASDAQ: FRG) (“Franchise Group” or the “Company”) today announced it will release its fourth quarter and full year 2020 financial results on March 10, 2021. Franchise Group will …
Completed Transformative Year with Q4 2020 Revenue Up 10% Year-Over-Year, Full Year 2020 Revenue up 14% Well Positioned for Growth in 2021 BEDFORD, Mass., March 04, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint …
TORONTO, March 04, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will attend and present at the H.C. Wainwright Annual Global …
Fourth Quarter 2020 Results: Record Revenue of $295.0 million, growing more than 3,400% year-over-year Record Billable tests delivered approximately 3.2 million, approximately 230 times the volume of fourth quarter of 2019 Gross Margin improved over 8 …
AUSTIN, Texas, March 04, 2021 (GLOBE NEWSWIRE) -- Chuy’s Holdings, Inc. (NASDAQ:CHUY) today announced financial results for the 13-week and 52-week periods ended December 27, 2020. Selected monthly comparable restaurant sales and average weekly sales per …
• Significant progress made across liver and metabolic diseases, retinal diseases and cancer during fourth quarter 2020: • Presented first-in-human results from Phase 1 clinical trial of NGM621 in patients with geographic atrophy (GA) at the …
REDMOND, Wash., March 04, 2021 (GLOBE NEWSWIRE) -- MicroVision, Inc. (NASDAQ: MVIS), a leader in MEMS based solid state automotive lidar and micro-display technology for augmented reality, today announced that it will report its fourth quarter and full …
NASHVILLE, Tenn., March 04, 2021 (GLOBE NEWSWIRE) -- SmileDirectClub, Inc. (Nasdaq: SDC), the next generation oral care company with the first medtech platform for teeth straightening, today announced its financial results for the fourth quarter and year …
TEMPE, Ariz., March 04, 2021 (GLOBE NEWSWIRE) -- Wrap Technologies, Inc. (Nasdaq: WRAP) (the “Company”), a global leader in innovative public safety technologies and services, today announced results for its fourth quarter and fiscal year ended December 31 …
LEXINGTON, Mass., March 04, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced financial results for the fourth quarter and full year ended December 31, 2020. Recent …
COPENHAGEN, Denmark, March 04, 2021 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technologies to create product candidates that address unmet medical needs, today announced that …
CHARLOTTESVILLE, Va., March 04, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), an innovative biopharmaceutical company developing novel therapies that enhance the body’s ability to deliver oxygen to …
- Approximately 363,000 Courses of Oral TPOXX® Delivered to U.S. Government in 2020 – - International Contracts for the Purchase of up to Approximately $47 Million of Oral TPOXX® Since April 2020 – - Corporate Update Conference Call Today at 4:30 PM ET - …
Exceeds prior expectations for fourth quarter and full year 2020 results Doubling of markets expected for 2021 SAN FRANCISCO, March 04, 2021 (GLOBE NEWSWIRE) -- Opendoor Technologies Inc. (Nasdaq: OPEN), a leading digital platform for residential real …
BELTSVILLE, Md., March 04, 2021 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, …
THE WOODLANDS, Texas, March 04, 2021 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), will release its fourth quarter and full-year 2020 financial results on Wednesday, March 10, 2021 after the markets close. Management will conduct a …
01 days 23:23:11
